CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism

Conclusion: CD44ICD promotes breast cancer stemness via PFKFB4-mediated glycolysis, and therapies that target PFKFB4 (e.g., 5MPN therapy) may lead to improved outcomes for cancer patients.
Source: Theranostics - Category: Molecular Biology Authors: Tags: Research Paper Source Type: research